BOLKEN; Tove

Patent Applications and Registrations

Patent applications and USPTO patent grants for BOLKEN; Tove.The latest application filed is for "antiviral drugs for treatment or prevention of dengue infection".

Company Profile

0.16.8

BOLKEN; Tove - Keizer OR
Bolken; Tove - N. Keizer OR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antiviral Drugs For Treatment Or Prevention Of Dengue Infection App 20160250233 - OLSEN; Chelsea ; et al.	2016-09-01
Antiviral drugs for treatment or prevention of dengue infection Grant 9,353,051 - Byrd , et al. May 31, 2	2016-05-31
ST-246 liquid formulations Grant 9,233,097 - Tyavanagimatt , et al. January 12, 2	2016-01-12
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with Arenaviruses Grant 9,115,065 - Dai , et al. August 25, 2	2015-08-25
Sulfonyl Semicarbazides, Semicarbazides And Ureas,pharmaceutical Compositions Thereof, And Methods For Treating Hemorrhagic Fever Viruses, Including Infections Associated With Arenaviruses App 20140378681 - Dai; Dongcheng ; et al.	2014-12-25
Antiviral drugs for treatment of arenavirus infection Grant 8,871,746 - Dai , et al. October 28, 2	2014-10-28
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses Grant 8,664,274 - Dai , et al. March 4, 2	2014-03-04
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses Grant 8,658,697 - Dai , et al. February 25, 2	2014-02-25
Anti-viral drugs for treatment of arenavirus infection Grant 8,629,170 - Hruby , et al. January 14, 2	2014-01-14
Antiviral Drugs for Treatement or Prevention of Dengue Infection App 20130303491 - Byrd; Chelsea M. ; et al.	2013-11-14
Antiviral drugs for treatment or prevention of dengue infection Grant 8,518,960 - Byrd , et al. August 27, 2	2013-08-27
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses Grant 8,410,149 - Dai , et al. April 2, 2	2013-04-02
Antiviral Drugs for Treatment of Arenavirus Infection App 20120071447 - Dai; Dongcheng ; et al.	2012-03-22
Sulfonyl Semicarbazides, Semicarbazides And Ureas, Pharmaceutical Compositions Thereof, And Methods For Treating Hemorrhagic Fever Viruses, Including Infections Associated With Arenaviruses App 20120022027 - Dai; Dongcheng ; et al.	2012-01-26
Anti-Viral Drugs for Treatment of Arenavirus Infection App 20110172281 - Hruby; Dennis E. ; et al.	2011-07-14
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses App 20110118505 - Dai; Dongcheng ; et al.	2011-05-19
Antiviral Drugs for Treatment or Prevention of Dengue Infection App 20100189685 - Byrd; Chelsea M. ; et al.	2010-07-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.